183 related articles for article (PubMed ID: 28186594)
21. Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.
Vejbaesya S; Sae-Tam P; Khuhapinant A; Srinak D
Hum Immunol; 2014 Jul; 75(7):673-6. PubMed ID: 24755352
[TBL] [Abstract][Full Text] [Related]
22. KIR-HLA distribution in a Vietnamese population from Hanoi.
Amorim LM; van Tong H; Hoan NX; Vargas LB; Ribeiro EMSF; Petzl-Erler ML; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Hum Immunol; 2018 Feb; 79(2):93-100. PubMed ID: 29191786
[TBL] [Abstract][Full Text] [Related]
23. Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
Middleton D; Diler AS; Meenagh A; Sleator C; Gourraud PA
Tissue Antigens; 2009 Jun; 73(6):553-60. PubMed ID: 19493232
[TBL] [Abstract][Full Text] [Related]
24. Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population.
Zhi D; Sun C; Sedimbi SK; Luo F; Shen S; Sanjeevi CB
Diabetes Metab Res Rev; 2011 Nov; 27(8):872-7. PubMed ID: 22069276
[TBL] [Abstract][Full Text] [Related]
25. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Olsson M; Sun JY; Senitzer D; Bergquist A; Schrumpf E; Thorsby E; Lie BA
J Hepatol; 2007 May; 46(5):899-906. PubMed ID: 17383044
[TBL] [Abstract][Full Text] [Related]
26. [Receptor-ligand analysis of killer cell Ig-like receptor in Jiangsu Han population].
Jiang LX; Xu LH; Qi CP; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):863-5. PubMed ID: 22863597
[TBL] [Abstract][Full Text] [Related]
27. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.
Levinson RD; Du Z; Luo L; Monnet D; Tabary T; Brezin AP; Zhao L; Gjertson DW; Holland GN; Reed EF; Cohen JH; Rajalingam R
Genes Immun; 2008 Apr; 9(3):249-58. PubMed ID: 18340360
[TBL] [Abstract][Full Text] [Related]
28. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks.
Capittini C; Tinelli C; Guarene M; Pasi A; Badulli C; Sbarsi I; Garlaschelli F; Cremaschi AL; Pizzochero C; Monti C; Salvaneschi L; Martinetti M
Genes Immun; 2012 Sep; 13(6):452-7. PubMed ID: 22573115
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma.
Choi H; Baek IC; Park SA; Park JS; Jeun SS; Kim TG; Ahn S
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510895
[TBL] [Abstract][Full Text] [Related]
30. Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival.
Beksac K; Beksac M; Dalva K; Karaagaoglu E; Tirnaksiz MB
PLoS One; 2015; 10(7):e0132526. PubMed ID: 26181663
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
32. KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation.
Littera R; Piredda G; Argiolas D; Lai S; Congeddu E; Ragatzu P; Melis M; Carta E; Michittu MB; Valentini D; Cappai L; Porcella R; Alba F; Serra M; Loi V; Maddi R; Orrù S; La Nasa G; Caocci G; Cusano R; Arras M; Frongia M; Pani A; Carcassi C
PLoS One; 2017; 12(7):e0180831. PubMed ID: 28686681
[TBL] [Abstract][Full Text] [Related]
33. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
[TBL] [Abstract][Full Text] [Related]
34. Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease.
Augusto DG; Lobo-Alves SC; Melo MF; Pereira NF; Petzl-Erler ML
PLoS One; 2012; 7(7):e39991. PubMed ID: 22768326
[TBL] [Abstract][Full Text] [Related]
35. HLA system affects the age-at-onset in chronic myeloid leukemia.
Oguz FS; Kalayoglu S; Diler AS; Tozkir H; Sargin D; Carin M; Dorak MT
Am J Hematol; 2003 Aug; 73(4):256-62. PubMed ID: 12879429
[TBL] [Abstract][Full Text] [Related]
36. KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.
Shen M; Linn YC; Ren EC
Immunogenetics; 2016 Feb; 68(2):133-44. PubMed ID: 26649563
[TBL] [Abstract][Full Text] [Related]
37. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
[TBL] [Abstract][Full Text] [Related]
38. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
39. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
[TBL] [Abstract][Full Text] [Related]
40. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]